21 – 30 of 399
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants
- Contribution to journal › Article
-
Mark
Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants
- Contribution to journal › Article
-
Mark
Clinical, splicing, and functional analysis to classify BRCA2 exon 3 variants : Application of a points-based ACMG/AMP approach
- Contribution to journal › Article
- 2021
-
Mark
Precision oncology of high-grade ovarian cancer defined through targeted sequencing
- Contribution to journal › Article
-
Mark
CDKN2A genetic testing in melanoma-prone families in Sweden in the years 2015-2020 : implications for novel national recommendations
- Contribution to journal › Article
-
Mark
Spatial deconvolution of HER2-positive breast cancer delineates tumor-associated cell type interactions
- Contribution to journal › Article
-
Mark
Serum selenium, selenoprotein P and glutathione peroxidase 3 as predictors of mortality and recurrence following breast cancer diagnosis: A multicentre cohort study
- Contribution to journal › Article
-
Mark
Preexisting Somatic Mutations of Estrogen Receptor Alpha (ESR1) in Early-Stage Primary Breast Cancer
- Contribution to journal › Article
-
Mark
The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant
- Contribution to journal › Article
-
Mark
Molecular analyses of triple-negative breast cancer in the young and elderly
- Contribution to journal › Article
